Biogen Files New Drug Application for Aducanumab in Japan

Go back to Biogen Files New Drug Application for Aducanumab in Japan
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 215.63 -0.4 (0.19%)
Previous Close $216.03    52 Week High $333.65 
Open $215.74    52 Week Low $223.02 
Day High $219.72    P/E 27.61 
Day Low $214.08    EPS $7.81 
Volume 778,292